{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T23:24:25Z","timestamp":1794093865516,"version":"4.8.0"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"S2","license":[{"start":{"date-parts":[[2026,1,29]],"date-time":"2026-01-29T00:00:00Z","timestamp":1769644800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,1,29]],"date-time":"2026-01-29T00:00:00Z","timestamp":1769644800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Aarhus University Hospital","id":[{"id":"https:\/\/ror.org\/040r8fr65","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Cancer Surviv"],"published-print":{"date-parts":[[2026,10]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Purpose<\/jats:title>\n                    <jats:p>Rectal cancer survivors are at risk of late adverse effects that impair quality of life. This study evaluates the cost-utility of a patient-led follow-up programme introduced in the Danish FURCA randomised controlled trial (RCT), aimed at improving patient outcomes and optimising healthcare resource use compared to standard hospital-based follow-up.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>The cost-utility analysis was performed from a societal perspective over a 3-year horizon, incorporating healthcare costs, prescription drug use, productivity losses, all derived from Danish register data, and quality-adjusted life years (QALYs) derived from RCT-collected EQ-5D-5L data. Incremental cost-effectiveness was assessed using regression models and non-parametric bootstrapping, with subgroup and sensitivity analyses exploring heterogeneity in outcomes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>A total of 336 patients were randomised to intervention and control groups. Over 3 years, mean healthcare costs were \u20ac40,208 for the intervention group and \u20ac41,190 for the control group (difference \u2212\u20ac980; 95% CI \u2212\u20ac7120 to \u20ac5159). Mean QALYs were 2.24 and 2.20, respectively (difference 0.028; 95% CI \u22120.106 to 0.163). The incremental cost-effectiveness ratio was \u2212\u20ac35,048 per QALY gained, indicating dominance. Scatterplots of bootstrapped incremental cost-effectiveness ratios (ICERs) revealed iterations in all four quadrants, reflecting substantial uncertainty in both costs and effects. The probability of cost-effectiveness at a \u20ac30,000 threshold was below 70%.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Patient-led follow-up resulted in comparable QALYs and costs relative to standard hospital-based follow-up. The probability of cost-effectiveness at a conventional willingness-to-pay threshold reached up to 70%.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Implications for cancer survivors<\/jats:title>\n                    <jats:p>Patient-led models may enable tailored delivery of specialist care to patients with greatest need, alongside balanced resource utilisation.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s11764-026-01976-9","type":"journal-article","created":{"date-parts":[[2026,1,29]],"date-time":"2026-01-29T22:13:47Z","timestamp":1769724827000},"page":"1467-1478","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Cost-Utility analysis of Patient-Led Follow-Up after Rectal Cancer Compared to Standard Follow-Up: A three-year follow-up of the FURCA Randomised Controlled Trial"],"prefix":"10.1007","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3701-074X","authenticated-orcid":false,"given":"Bettina Wulff","family":"Ris\u00f8r","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6717-5003","authenticated-orcid":false,"given":"Nasrin","family":"Tayyari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2680-6999","authenticated-orcid":false,"given":"Liza","family":"Sopina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5411-4826","authenticated-orcid":false,"given":"Therese","family":"Juul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S\u00f8ren","family":"Laurberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6225-1559","authenticated-orcid":false,"given":"Henriette Vind","family":"Thaysen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4979-5863","authenticated-orcid":false,"given":"Ida","family":"Hovdenak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,29]]},"reference":[{"key":"1976_CR1","doi-asserted-by":"publisher","unstructured":"Wong MCS, Huang J, Lok V, Wang J, Fung F, Ding H, et al. Differences in incidence and mortality trends of colorectal cancer worldwide based on sex, age, and anatomic location. Clin Gastroenterol Hepatol. 2021;19(5):955\u201366.e61.\u00a0https:\/\/doi.org\/10.1016\/j.cgh.2020.02.026.","DOI":"10.1016\/j.cgh.2020.02.026"},{"issue":"3","key":"1976_CR2","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209\u201349. https:\/\/doi.org\/10.3322\/caac.21660.","journal-title":"CA Cancer J Clin"},{"key":"1976_CR3","unstructured":"Regionernes Kliniske Kvalitetsprogram (RKKP). Dansk Kolorektal Cancer Database \u00c5rsrapport 1. januar 2023 - 31. december 2023 [Danish Colorectal Cancer Database Annual Report January 1 to December 31 2023][Internet]. Aarhus: Regionernes Kliniske Kvalitets program; 2024 [cited 2026 January 28]. Available from: https:\/\/data-sundk.dk\/aarsrapporter\/dccg\/"},{"issue":"7","key":"1976_CR4","doi-asserted-by":"publisher","first-page":"e37","DOI":"10.1111\/j.1463-1318.2009.02012.x","volume":"12","author":"S B\u00fclow","year":"2010","unstructured":"B\u00fclow S, Harling H, Iversen LH, Ladelund S. Improved survival after rectal cancer in Denmark. Colorectal Dis. 2010;12(7):e37-42. https:\/\/doi.org\/10.1111\/j.1463-1318.2009.02012.x.","journal-title":"Colorectal Dis"},{"issue":"6","key":"1976_CR5","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1097\/COC.0b013e3181fe41ed","volume":"34","author":"L Cheng","year":"2011","unstructured":"Cheng L, Eng C, Nieman LZ, Kapadia AS, Du XL. Trends in colorectal cancer incidence by anatomic site and disease stage in the United States from 1976 to 2005. Am J Clin Oncol. 2011;34(6):573\u201380. https:\/\/doi.org\/10.1097\/COC.0b013e3181fe41ed.","journal-title":"Am J Clin Oncol"},{"issue":"4","key":"1976_CR6","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1111\/codi.14503","volume":"21","author":"VP Bastiaenen","year":"2019","unstructured":"Bastiaenen VP, Hovdenak Jakobsen I, Labianca R, Martling A, Morton DG, Primrose JN, et al. Consensus and controversies regarding follow-up after treatment with curative intent of nonmetastatic colorectal cancer: a synopsis of guidelines used in countries represented in the European Society of Coloproctology. Colorectal Dis. 2019;21(4):392\u2013416. https:\/\/doi.org\/10.1111\/codi.14503.","journal-title":"Colorectal Dis"},{"key":"1976_CR7","doi-asserted-by":"publisher","DOI":"10.1111\/codi.15519","author":"T Juul","year":"2021","unstructured":"Juul T, Br\u00e4uner AB, Drewes AM, Emmertsen KJ, Krogh K, Laurberg S, et al. Systematic screening for late sequelae after colorectal cancer - a feasibility study. Colorectal Dis. 2021. https:\/\/doi.org\/10.1111\/codi.15519.","journal-title":"Colorectal Dis"},{"key":"1976_CR8","doi-asserted-by":"publisher","unstructured":"Mikkelsen AH, Thy\u00f8 A, Seyer-Hansen AD, Drewes AM, Laursen BS, Christensen P, et al. Sexual dysfunction after colorectal and anal cancer-treatment in nurse-led sexological clinics. Colorectal Dis. 2025;27(2):e70018.\u00a0https:\/\/doi.org\/10.1111\/codi.70018.","DOI":"10.1111\/codi.70018"},{"key":"1976_CR9","doi-asserted-by":"publisher","unstructured":"Mekhael M, Kristensen H, Borre M, Drewes AM, Emmertsen KJ, Fassov J, et al. Treatment of low anterior resection syndrome in specialized multidisciplinary late sequelae clinics: a prospective cohort study. Ann Surg. 2025.\u00a0https:\/\/doi.org\/10.1097\/sla.0000000000006714.","DOI":"10.1097\/sla.0000000000006714"},{"issue":"1","key":"1976_CR10","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1080\/0284186x.2023.2168214","volume":"62","author":"M Mekhael","year":"2023","unstructured":"Mekhael M, Larsen HM, Lauritzen MB, Thorlacius-Ussing O, Laurberg S, Krogh K, et al. Bowel dysfunction following pelvic organ cancer: a prospective study on the treatment effect in nurse-led late sequelae clinics. Acta Oncol. 2023;62(1):70\u20139. https:\/\/doi.org\/10.1080\/0284186x.2023.2168214.","journal-title":"Acta Oncol"},{"issue":"7","key":"1976_CR11","doi-asserted-by":"publisher","first-page":"2063","DOI":"10.1007\/s00520-017-3595-x","volume":"25","author":"L Batehup","year":"2017","unstructured":"Batehup L, Porter K, Gage H, Williams P, Simmonds P, Lowson E, et al. Follow-up after curative treatment for colorectal cancer: longitudinal evaluation of patient initiated follow-up in the first 12 months. Support Care Cancer. 2017;25(7):2063\u201373. https:\/\/doi.org\/10.1007\/s00520-017-3595-x.","journal-title":"Support Care Cancer"},{"issue":"1","key":"1976_CR12","doi-asserted-by":"publisher","DOI":"10.1186\/s13063-017-2245-4","volume":"18","author":"M Jefford","year":"2017","unstructured":"Jefford M, Emery J, Grunfeld E, Martin A, Rodger P, Murray AM, et al. SCORE: Shared care of Colorectal cancer survivors: protocol for a randomised controlled trial. Trials. 2017;18(1):506. https:\/\/doi.org\/10.1186\/s13063-017-2245-4.","journal-title":"Trials"},{"issue":"8","key":"1976_CR13","doi-asserted-by":"publisher","first-page":"1014","DOI":"10.1634\/theoncologist.2015-0533","volume":"21","author":"M Jefford","year":"2016","unstructured":"Jefford M, Gough K, Drosdowsky A, Russell L, Aranda S, Butow P, et al. A randomized controlled trial of a nurse-led supportive care package (SurvivorCare) for survivors of colorectal cancer. Oncologist. 2016;21(8):1014\u201323. https:\/\/doi.org\/10.1634\/theoncologist.2015-0533.","journal-title":"Oncologist"},{"issue":"1","key":"1976_CR14","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1093\/bmb\/ldy011","volume":"126","author":"M Barbieri","year":"2018","unstructured":"Barbieri M, Richardson G, Paisley S. The cost-effectiveness of follow-up strategies after cancer treatment: a systematic literature review. Br Med Bull. 2018;126(1):85\u2013100. https:\/\/doi.org\/10.1093\/bmb\/ldy011.","journal-title":"Br Med Bull"},{"issue":"6","key":"1976_CR15","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1586\/14737167.2015.1087316","volume":"15","author":"M Meregaglia","year":"2015","unstructured":"Meregaglia M, Cairns J. Economic evaluations of follow-up strategies for cancer survivors: a systematic review and quality appraisal of the literature. Expert Rev Pharmacoecon Outcomes Res. 2015;15(6):913\u201329. https:\/\/doi.org\/10.1586\/14737167.2015.1087316.","journal-title":"Expert Rev Pharmacoecon Outcomes Res"},{"key":"1976_CR16","doi-asserted-by":"publisher","DOI":"10.1007\/s11764-023-01383-4","author":"JAM Vos","year":"2023","unstructured":"Vos JAM, El Alili M, Duineveld LAM, Wieldraaijer T, Wind J, Sert E, et al. Cost-effectiveness of general practitioner- versus surgeon-led colon cancer survivorship care: an economic evaluation alongside a randomised controlled trial. J Cancer Surviv. 2023. https:\/\/doi.org\/10.1007\/s11764-023-01383-4.","journal-title":"J Cancer Surviv"},{"key":"1976_CR17","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejso.2020.12.018","author":"SM Qaderi","year":"2021","unstructured":"Qaderi SM, Swartjes H, Vromen H, Bremers AJA, Custers JAE, de Wilt JHW. Acceptability, quality of life and cost overview of a remote follow-up plan for patients with colorectal cancer. Eur J Surg Oncol. 2021. https:\/\/doi.org\/10.1016\/j.ejso.2020.12.018.","journal-title":"Eur J Surg Oncol"},{"key":"1976_CR18","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejso.2022.06.023","author":"N Bhimani","year":"2022","unstructured":"Bhimani N, Wong GY, Molloy C, Dieng M, Hugh TJ. Cost of colorectal cancer by treatment type from different health economic perspectives: a systematic review. Eur J Surg Oncol. 2022. https:\/\/doi.org\/10.1016\/j.ejso.2022.06.023.","journal-title":"Eur J Surg Oncol"},{"key":"1976_CR19","doi-asserted-by":"publisher","DOI":"10.14196\/mjiri.31.115","volume":"31","author":"Z Vahdatimanesh","year":"2017","unstructured":"Vahdatimanesh Z, Zendehdel K, Kbari Sari AA, Farhan F, Nahvijou A, Delavari A, et al. Economic burden of colorectal cancer in Iran in 2012. Med J Islam Repub Iran. 2017;31:115. https:\/\/doi.org\/10.14196\/mjiri.31.115.","journal-title":"Med J Islam Repub Iran"},{"issue":"7","key":"1976_CR20","doi-asserted-by":"publisher","first-page":"1000","DOI":"10.1136\/ijgc-2019-001074","volume":"30","author":"I Luqman","year":"2020","unstructured":"Luqman I, Wickham-Joseph R, Cooper N, Boulter L, Patel N, Kumarakulasingam P, et al. Patient-initiated follow-up for low-risk endometrial cancer: a cost-analysis evaluation. Int J Gynecol Cancer. 2020;30(7):1000\u20134.","journal-title":"Int J Gynecol Cancer"},{"issue":"2","key":"1976_CR21","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1080\/0284186x.2016.1267400","volume":"56","author":"I Hovdenak Jakobsen","year":"2017","unstructured":"Hovdenak Jakobsen I, Juul T, Bernstein I, Christensen P, Jensen FS, Johansen C, et al. Follow-up after rectal cancer: developing and testing a novel patient-led follow-up program. Study protocol. Acta Oncol. 2017;56(2):307\u201313. https:\/\/doi.org\/10.1080\/0284186x.2016.1267400.","journal-title":"Acta Oncol"},{"issue":"3","key":"1976_CR22","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1007\/s10198-013-0471-6","volume":"14","author":"D Husereau","year":"2013","unstructured":"Husereau D, Drummond M, Petrou S, Carswell C, Moher D, Greenberg D, et al. Consolidated Health Economic Evaluation Reporting Standards (CHEERS) statement. Eur J Health Econ. 2013;14(3):367\u201372.","journal-title":"Eur J Health Econ"},{"key":"1976_CR23","unstructured":"Sundhedsstyrelsen. Opf\u00f8lgningsprogram for tyk-og endetarmskr\u00e6ft [Follow-up Program after Colorectal Cancer]. Copenhagen: Sundhedsstyrelsen; 2015 [cited 2025 January 28]. Available from: https:\/\/sundhedsstyrelsen.dk\/da\/udgivelser\/2015\/%7E\/media\/95F5F42112AF4463A509D6858DDDAD52.ashx?m=.pdf"},{"key":"1976_CR24","unstructured":"Danish Colorectal Cancer Group (DCCG). DCCG\u2019s nationale retningslinjer for diagnostik og behandling af kolorektal cancer: Postoperativ Kontrol [National Guidelines for diagnostics and treatment of colorectal cancer: Postoperative Control]. Copenhagen; 2012 [cited 2025 January 28]. Available from: https:\/\/dccg.dk\/wp-content\/uploads\/2023\/06\/Postoperativ-kontrol.pdf"},{"issue":"4","key":"1976_CR25","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1007\/s40258-021-00639-3","volume":"19","author":"CE Jensen","year":"2021","unstructured":"Jensen CE, S\u00f8rensen SS, Gudex C, Jensen MB, Pedersen KM, Ehlers LH. The Danish EQ-5D-5L value set: a hybrid model using cTTO and DCE data. Appl Health Econ Health Policy. 2021;19(4):579\u201391.","journal-title":"Appl Health Econ Health Policy"},{"issue":"7 Suppl","key":"1976_CR26","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1177\/1403494810394718","volume":"39","author":"JS Andersen","year":"2011","unstructured":"Andersen JS, Olivarius NF, Krasnik A. The Danish National Health Service Register. Scand J Public Health. 2011;39(7 Suppl):34\u20137.","journal-title":"Scand J Public Health"},{"issue":"7 Suppl","key":"1976_CR27","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1177\/1403494811401482","volume":"39","author":"E Lynge","year":"2011","unstructured":"Lynge E, Sandegaard JL, Rebolj M. The Danish National Patient Register. Scand J Public Health. 2011;39(7 Suppl):30\u20133.","journal-title":"Scand J Public Health"},{"issue":"7 Suppl","key":"1976_CR28","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1177\/1403494810394717","volume":"39","author":"HW Kildemoes","year":"2011","unstructured":"Kildemoes HW, S\u00f8rensen HT, Hallas J. The Danish National Prescription Registry. Scand J Public Health. 2011;39(7 Suppl):38\u201341.","journal-title":"Scand J Public Health"},{"key":"1976_CR29","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2458-12-661","volume":"12","author":"CM Stapelfeldt","year":"2012","unstructured":"Stapelfeldt CM, Jensen C, Andersen NT, Fleten N, Nielsen CV. Validation of sick leave measures: self-reported sick leave and sickness benefit data from a Danish national register compared to multiple workplace-registered sick leave spells in a Danish municipality. BMC Public Health. 2012;12:661.","journal-title":"BMC Public Health"},{"key":"1976_CR30","volume-title":"Claxton K, Stoddart GL","author":"MFSM Drummond","year":"2015","unstructured":"Drummond MFSM. Claxton K, Stoddart GL. Torrance GW Methods for the economic evaluation of health care programmes.: Oxford University Press; 2015."},{"issue":"12","key":"1976_CR31","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1007\/s40273-014-0193-3","volume":"32","author":"R Faria","year":"2014","unstructured":"Faria R, Gomes M, Epstein D, White IR. A guide to handling missing data in cost-effectiveness analysis conducted within randomised controlled trials. Pharmacoeconomics. 2014;32(12):1157\u201370.","journal-title":"Pharmacoeconomics"},{"issue":"5","key":"1976_CR32","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1002\/hec.944","volume":"14","author":"A Manca","year":"2005","unstructured":"Manca A, Hawkins N, Sculpher MJ. Estimating mean QALYs in trial-based cost-effectiveness analysis: the importance of controlling for baseline utility. Health Econ. 2005;14(5):487\u201396. https:\/\/doi.org\/10.1002\/hec.944.","journal-title":"Health Econ"},{"issue":"5 Pt 1","key":"1976_CR33","doi-asserted-by":"publisher","first-page":"487","DOI":"10.2165\/00019053-199813050-00002","volume":"13","author":"A Desgagn\u00e9","year":"1998","unstructured":"Desgagn\u00e9 A, Castilloux AM, Angers JF, LeLorier J. The use of the bootstrap statistical method for the pharmacoeconomic cost analysis of skewed data. Pharmacoeconomics. 1998;13(5 Pt 1):487\u201397. https:\/\/doi.org\/10.2165\/00019053-199813050-00002.","journal-title":"Pharmacoeconomics"},{"issue":"4","key":"1976_CR34","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1002\/hec.941","volume":"14","author":"A Briggs","year":"2005","unstructured":"Briggs A, Nixon R, Dixon S, Thompson S. Parametric modelling of cost data: some simulation evidence. Health Econ. 2005;14(4):421\u20138. https:\/\/doi.org\/10.1002\/hec.941.","journal-title":"Health Econ"},{"issue":"4","key":"1976_CR35","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1002\/(sici)1099-1050(199707)6:4<327::aid-hec282>3.0.co;2-w","volume":"6","author":"AH Briggs","year":"1997","unstructured":"Briggs AH, Wonderling DE, Mooney CZ. Pulling cost-effectiveness analysis up by its bootstraps: a non-parametric approach to confidence interval estimation. Health Econ. 1997;6(4):327\u201340. https:\/\/doi.org\/10.1002\/(sici)1099-1050(199707)6:4<327::aid-hec282>3.0.co;2-w.","journal-title":"Health Econ"},{"key":"1976_CR36","doi-asserted-by":"publisher","DOI":"10.1007\/s11764-023-01410-4","author":"I Hovdenak","year":"2023","unstructured":"Hovdenak I, Thaysen HV, Bernstein IT, Christensen P, Hauberg A, Iversen LH, et al. Quality of life and symptom burden after rectal cancer surgery: a randomised controlled trial comparing patient-led versus standard follow-up. J Cancer Surviv. 2023. https:\/\/doi.org\/10.1007\/s11764-023-01410-4.","journal-title":"J Cancer Surviv"},{"issue":"9","key":"1976_CR37","doi-asserted-by":"publisher","first-page":"1130","DOI":"10.1080\/0284186x.2021.1950924","volume":"60","author":"I Hovdenak Jakobsen","year":"2021","unstructured":"Hovdenak Jakobsen I, Vind Thaysen H, Laurberg S, Johansen C, Juul T. Patient-led follow-up reduces outpatient doctor visits and improves patient satisfaction. One-year analysis of secondary outcomes in the randomised trial Follow-Up after Rectal CAncer (FURCA). Acta Oncol. 2021;60(9):1130\u20139. https:\/\/doi.org\/10.1080\/0284186x.2021.1950924.","journal-title":"Acta Oncol"},{"issue":"6","key":"1976_CR38","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1007\/s004230000144","volume":"385","author":"L Staib","year":"2000","unstructured":"Staib L, Link KH, Beger HG. Follow-up in colorectal cancer: cost-effectiveness analysis of established and novel concepts. Langenbecks Arch Surg. 2000;385(6):412\u201320. https:\/\/doi.org\/10.1007\/s004230000144.","journal-title":"Langenbecks Arch Surg"},{"issue":"9","key":"1976_CR39","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1111\/j.1463-1318.2011.02716.x","volume":"13","author":"P Wille-J\u00f8rgensen","year":"2011","unstructured":"Wille-J\u00f8rgensen P, Balleby L. Follow-up in colorectal cancer: questions to be answered. Colorectal Dis. 2011;13(9):959\u201360. https:\/\/doi.org\/10.1111\/j.1463-1318.2011.02716.x.","journal-title":"Colorectal Dis"},{"issue":"30","key":"1976_CR40","doi-asserted-by":"publisher","first-page":"5557","DOI":"10.1002\/sim.3112","volume":"26","author":"C Castelli","year":"2007","unstructured":"Castelli C, Combescure C, Foucher Y, Daures JP. Cost-effectiveness analysis in colorectal cancer using a semi-Markov model. Stat Med. 2007;26(30):5557\u201371. https:\/\/doi.org\/10.1002\/sim.3112.","journal-title":"Stat Med"},{"issue":"6","key":"1976_CR41","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1093\/jjco\/hyae018","volume":"54","author":"Y Takayama","year":"2024","unstructured":"Takayama Y, Tsukamoto S, Kudose Y, Takamizawa Y, Moritani K, Esaki M, et al. Cost-effectiveness of surveillance intervals after curative resection of colorectal cancer. Jpn J Clin Oncol. 2024;54(6):637\u201346. https:\/\/doi.org\/10.1093\/jjco\/hyae018.","journal-title":"Jpn J Clin Oncol"},{"key":"1976_CR42","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.amsu.2019.07.004","volume":"45","author":"KN Alsowaina","year":"2019","unstructured":"Alsowaina KN, Schlachta CM, Alkhamesi NA. Cost-effectiveness of current approaches in rectal surgery. Ann Med Surg (Lond). 2019;45:36\u20139. https:\/\/doi.org\/10.1016\/j.amsu.2019.07.004.","journal-title":"Ann Med Surg (Lond)"},{"issue":"1","key":"1976_CR43","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1080\/00015458.2012.11680791","volume":"112","author":"L Di Cristofaro","year":"2012","unstructured":"Di Cristofaro L, Scarpa M, Angriman I, Perissinotto E, Ruffolo C, Frego M, et al. Cost-effectiveness analysis of postoperative surveillance protocols following radical surgery for colorectal cancer. Acta Chir Belg. 2012;112(1):24\u201332. https:\/\/doi.org\/10.1080\/00015458.2012.11680791.","journal-title":"Acta Chir Belg"},{"issue":"10","key":"1976_CR44","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1111\/codi.12970","volume":"17","author":"A Siddika","year":"2015","unstructured":"Siddika A, Tolia-Shah D, Pearson TE, Richardson NG, Ross AH. Remote surveillance after colorectal cancer surgery: an effective alternative to standard clinic-based follow-up. Colorectal Dis. 2015;17(10):870\u20135. https:\/\/doi.org\/10.1111\/codi.12970.","journal-title":"Colorectal Dis"},{"key":"1976_CR45","unstructured":"Indenrigs- og Sundhedsministeriet. Et bedre liv med og efter kr\u00e6ft - Kr\u00e6ftplan V [Improved quality of life for cancer patients and camcer survivors - Cancer Care Plan V]. Copenhagen; 2025 [cited 2026 January 28]. Available from: https:\/\/www.ism.dk\/Media\/638835090309035273\/Et-bedre-liv-med-og-efter-kraeft-kraeftplan-V-TILG.pdf"}],"container-title":["Journal of Cancer Survivorship"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11764-026-01976-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11764-026-01976-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11764-026-01976-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T23:02:38Z","timestamp":1794092558000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11764-026-01976-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,29]]},"references-count":45,"journal-issue":{"issue":"S2","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["1976"],"URL":"https:\/\/doi.org\/10.1007\/s11764-026-01976-9","relation":{},"ISSN":["1932-2259","1932-2267"],"issn-type":[{"value":"1932-2259","type":"print"},{"value":"1932-2267","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,29]]},"assertion":[{"value":"23 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study complied with the ethical principles in the Helsinki Declaration and was approved by the National Committee on Health Research Ethics (File no. 1\u201310-72\u2013218-15). The study was also notified to the regional data review board in accordance with Danish data protection regulations (File no. 1-16-02-443-15).","order":1,"name":"Ethics","label":"Ethics approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Informed consent was obtained from all participants included in the study.","order":2,"name":"Ethics","label":"Consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":3,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}]}}